# Aldeyra Therapeutics, Inc.: Form 8-K, filed Mar 28, 2024

- Company: [Aldeyra Therapeutics, Inc.](/companies/aldx.md) (CIK 1341235)
- Form: 8-K
- Filed: 2024-03-28
- Accepted by EDGAR: Mar 28, 2024, 07:01 ET
- Period: 2024-03-28
- Accession: 0001213900-24-026871
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1341235/000121390024026871/ea0202743-8k_aldey.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1341235/000121390024026871/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1341235/000121390024026871/ea0202743-8k_aldey.htm

Filed Mar 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-026871. Last ingested by Listed: Nov 6, 2026, 14:45 ET. No prices; not investment advice.